Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CD19-CAR(Mem) T-cells |
Trade Name | |
Synonyms | CD19-CAR.CD45RA-negative T-cells |
Drug Descriptions |
CD19-CAR(Mem) T-cells are a preparation of CD45RA-negative T cells engineered to express a chimeric antigen receptor (CAR) targeting CD19, containing 4-1BB and CD3-zeta signaling domains and a variable fragment of a CD19 antibody, which may potentially lead to tumor cell lysis (PMID: 24888271). |
DrugClasses | CD19 Immune Cell Therapy 62 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CD19-CAR(Mem) T-cells | CD19-CAR(Mem) T-cells | 0 | 0 |
CD19-CAR(Mem) T-cells + Cyclophosphamide + Fludarabine + Mesna | CD19-CAR(Mem) T-cells Cyclophosphamide Fludarabine Mesna | 0 | 1 |